---
figid: PMC9658252__ijms-23-12820-g002
pmcid: PMC9658252
image_filename: ijms-23-12820-g002.jpg
figure_link: /pmc/articles/PMC9658252/figure/ijms-23-12820-f002/
number: Figure 2
figure_title: ''
caption: TriL reduced cerebral infarct area and neurological deficits of ischemia/reperfusion
  (I/R) rats. (A) Effects of TriL treatment (50, 100, 200 mg/kg p.o.) on cerebral
  infarct area at 24 h after reperfusion. The pale area represents infarct tissue,
  and the red-purple area normal tissue. Scale bar = 1 cm. (B) Infarction area by
  TTC staining. (C) Neurological deficit score. Each vertical bars represented mean
  Â± S.E. ** p < 0.01, *** p <0.001 compared with the I/R group (n = 5).
article_title: Trilinolein, a Natural Triacylglycerol, Protects Cerebral Ischemia
  through Inhibition of Neuronal Apoptosis and Ameliorates Intimal Hyperplasia via
  Attenuation of Migration and Modulation of Matrix Metalloproteinase-2 and RAS/MEK/ERK
  Signaling Pathway in VSMCs.
citation: Yuh-Fung Chen, et al. Int J Mol Sci. 2022 Nov;23(21):12820.
year: '2022'

doi: 10.3390/ijms232112820
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- trilinolein
- cerebrovascular diseases
- cerebral ischemia/reperfusion
- intimal hyperplasia
- PDGF-BB
- Ras/MEK/ERK signaling pathway
- MMP-2

---
